Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
United Therapeutics Corp (UTHR)  
$262.40 4.27 (1.65%) as of 4:30 Fri 5/3


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 47,262,000
Market Cap: 12.40(B)
Last Volume: 779,523 Avg Vol: 420,575
52 Week Range: $205.19 - $258.13
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:

    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   United Therapeutics is a biotechnology company. Through its subsidiary, Lung Biotechnology PBC, Co. is focused on addressing the acute national shortage of transplantable lungs and other organs with a variety of technologies that either delay the need for such organs or expand the supply. Co. markets and sells the following commercial therapies to treat pulmonary arterial hypertension: Remodulin® (treprostinil) Injection; Tyvaso® (treprostinil) Inhalation Solution; Orenitram® (treprostinil) Extended-Release Tablets; and Adcirca® (tadalafil) Tablets. In the U.S., Co. also markets and sells an oncology product, Unituxin® (dinutuximab) Injection, for the treatment of high-risk neuroblastoma.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 466,605 506,610 569,867 1,758,988
Total Sell Value $110,691,046 $119,828,977 $133,965,406 $428,642,279
Total People Sold 5 6 6 10
Total Sell Transactions 49 58 71 248
End Date 2024-02-04 2023-11-03 2023-05-05 2022-05-05

   
Records found: 2674
  Page 9 of 107  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Mahon Paul A EVP & GENERAL COUNSEL   •       –      –    2023-04-20 4 AS $223.63 $1,343,755 D/D (6,000) 36,599 2%     
   Mahon Paul A EVP & GENERAL COUNSEL   •       –      –    2023-04-20 4 OE $120.26 $721,560 D/D 6,000 42,599     -
   Rothblatt Martine A CHAIRPERSON & CEO   •       •      –    2023-04-19 4 AS $225.43 $1,808,988 D/D (8,000) 130 -0%     
   Rothblatt Martine A CHAIRPERSON & CEO   •       •      –    2023-04-19 4 OE $113.08 $904,640 D/D 8,000 8,130     -
   Rothblatt Martine A CHAIRPERSON & CEO   •       •      –    2023-04-18 4 AS $226.37 $1,814,271 D/D (8,000) 130 0%     
   Rothblatt Martine A CHAIRPERSON & CEO   •       •      –    2023-04-18 4 OE $113.08 $904,640 D/D 8,000 8,130     -
   Rothblatt Martine A CHAIRPERSON & CEO   •       •      –    2023-04-17 4 AS $230.02 $1,843,763 D/D (8,000) 130 0%     
   Rothblatt Martine A CHAIRPERSON & CEO   •       •      –    2023-04-17 4 OE $113.08 $904,640 D/D 8,000 8,130     -
   Rothblatt Martine A CHAIRPERSON & CEO   •       •      –    2023-04-14 4 AS $227.90 $1,827,876 D/D (8,000) 130 1%     
   Rothblatt Martine A CHAIRPERSON & CEO   •       •      –    2023-04-14 4 OE $113.08 $904,640 D/D 8,000 8,130     -
   Dwek Raymond   –       •      –    2023-04-14 4 D $228.72 $457,440 D/D (2,000) 0     -
   Dwek Raymond   –       •      –    2023-04-14 4 OE $63.90 $127,800 D/D 2,000 2,000     -
   Rothblatt Martine A CHAIRPERSON & CEO   •       •      –    2023-04-13 4 AS $225.80 $1,845,541 D/D (8,000) 130 -0%     
   Rothblatt Martine A CHAIRPERSON & CEO   •       •      –    2023-04-13 4 OE $113.08 $904,640 D/D 8,000 8,130     -
   Rothblatt Martine A CHAIRPERSON & CEO   •       •      –    2023-04-12 4 AS $225.71 $1,817,199 D/D (8,000) 130 2%     
   Rothblatt Martine A CHAIRPERSON & CEO   •       •      –    2023-04-12 4 OE $113.08 $904,640 D/D 8,000 8,130     -
   Rothblatt Martine A CHAIRPERSON & CEO   •       •      –    2023-04-11 4 AS $222.83 $1,804,555 D/D (8,000) 130 2%     
   Rothblatt Martine A CHAIRPERSON & CEO   •       •      –    2023-04-11 4 OE $113.08 $904,640 D/D 8,000 8,130     -
   Dwek Raymond   –       •      –    2023-04-10 4 D $223.07 $669,210 D/D (3,000) 0     -
   Dwek Raymond   –       •      –    2023-04-10 4 OE $63.90 $191,700 D/D 3,000 3,000     -
   Rothblatt Martine A CHAIRPERSON & CEO   •       •      –    2023-04-10 4 AS $222.70 $1,793,684 D/D (8,000) 130 2%     
   Rothblatt Martine A CHAIRPERSON & CEO   •       •      –    2023-04-10 4 OE $113.08 $904,640 D/D 8,000 8,130     -
   Rothblatt Martine A CHAIRPERSON & CEO   •       •      –    2023-04-06 4 AS $226.77 $1,832,925 D/D (8,000) 130 2%     
   Rothblatt Martine A CHAIRPERSON & CEO   •       •      –    2023-04-06 4 OE $113.08 $904,640 D/D 8,000 8,130     -
   Mahon Paul A EVP & GENERAL COUNSEL   •       –      –    2023-04-06 4 AS $231.93 $1,396,755 D/D (6,000) 36,599 2%     

  2674 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 9 of 107
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed